---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-192338"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2023-07-24T23:59:59+00:00"
generated_at: "2026-06-13T04:42:01.656265+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health signs $4.7M common stock offering at $2.75/share to investors

## Summary
- Sells 1,650,473 shares at $2.75/share to investors and 44,347 shares at $3.98/share to directors/officers.
- Gross proceeds ~$4.7M before fees; closing expected July 24, 2023.
- Placement agent A.G.P./Alliance Global Partners receives 7% fee (3.5% on insider shares).
- Officers and directors enter 90-day lock-up agreements restricting sale of company securities.
- No pre-funded warrants were sold in the offering.

## SEC filing metadata
- accession: 0001193125-23-192338
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2023-07-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000119312523192338/0001193125-23-192338-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000119312523192338/d558666d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-192338
- JSON: https://secwatch.observer/filing/0001193125-23-192338.json
- Plain text: https://secwatch.observer/filing/0001193125-23-192338.txt

## Key facts
- Material Agreements
  Aspira Women's Health Inc. entered into Securities Purchase Agreement with several investors (the Purchasers) valued at approximately $4.7 million (effective 2023-07-20).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: several investors (the Purchasers)
  - Value: approximately $4.7 million
  - Effective: 2023-07-20
  source text: On July 20, 2023, Aspira Women’s Health Inc., or Aspira, entered into a securities purchase agreement, or the Purchase Agreement, with several investors, or the Purchasers, relating to the issuance and sale of an aggregate of 1,694,820 shares of its common stock, par value $0.001 per share, or the Offering.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000119312523192338/0001193125-23-192338-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.